Drug Pipeline

BR1015-2 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07421375 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421388 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421401 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421414 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
Sponsors Running BR1015-2 Trials
Boryung Pharmaceutical Co., Ltd (4)
Disease Areas
Hypertension (4)
Get alerts when BR1015-2 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free